Method for diagnosing kidney disease comprising detecting the level of annexin A2
The present invention provides biomarkers for detecting kidney disease, selected from the oligonucleotide sequence, complementary sequence or derivatives, amino acid sequence or derivatives, fragment, variants, antibody of annexin A2 or S100A6 or combinations thereof. Moreover, the present invention also provides an assay kit and a method for kidney disease detecting, practically for the kidney disease resulting from acute tubular necrosis.
1. A method for diagnosing a kidney disease in a subject, comprising
providing a renal sample obtained from a subject, wherein the renal sample is a renal cortical tissue,
detecting in the renal sample a level of a biomarker, which is Annexin A2, and
determining, based on the level of the biomarker thus detected, whether the subject suffers from a kidney disease, which is acute kidney failure or acute tubular necrosis; wherein an elevated level of the biomarker in the subject relative to that in a healthy subject indicates that the subject suffers from the kidney disease.
2. The method of claim 1 , wherein the detecting step is performed by examining the protein level of Annexin A2.
3. The method of claim 2 , wherein the protein level of Annexin A2 is determined by an immune assay selected from the group consisting of ELISA, Western Blot, and immunohistochemical staining.
4. The method of claim 3 , wherein the immune assay is ELISA.
5. The method of claim 3 , wherein the immune assay is Western Blot.
6. The method of claim 3 , wherein the immune assay is immunohistochemical staining.
7. The method of claim 1 , wherein the detecting step is performed by examining the messenger RNA level of Annexin A2.
8. The method of claim 7 , wherein the RNA level of Annexin A2 is determined by real-time PCR.
9. The method of claim 7 , wherein the RNA level of Annexin A2 is determined by in situ hybridization.